$VATE
INNOVATE Corp. Stock $vate

$vate Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000100683723000063 Filed on May 10, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$368.8M	$317.9M	$412.8M
YoY Change	-5.97%	-22.99%	140.28%
Cost Of Revenue	$316.2M	$274.3M	$363.0M
YoY Change	-7.52%	-24.44%	156.9%
Gross Profit	$52.60M	$43.60M	$49.80M
YoY Change	4.57%	-12.45%	63.28%
Gross Profit Margin	14.26%	13.72%	12.06%
Selling, General & Admin	$41.10M	$41.70M	$42.60M
YoY Change	-2.38%	-2.11%	14.82%
% of Gross Profit	78.14%	95.64%	85.54%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$6.200M	$10.20M	$10.60M
YoY Change	-1.59%	-3.77%	70.97%
% of Gross Profit	11.79%	23.39%	21.29%
Operating Expenses	$41.10M	$41.70M	$42.60M
YoY Change	-2.38%	-2.11%	14.82%
Operating Profit	$5.800M	-$4.000M	$700.0K
YoY Change	-1550.0%	-671.43%	-106.42%
Interest Expense	$16.30M	$15.60M	$12.60M
YoY Change	30.4%	23.81%	-41.12%
% of Operating Profit	281.03%		1800.0%
Other Income/Expense, Net	$300.0K	$16.50M	-$100.0K
YoY Change	-80.0%	-16600.0%	-102.94%
Pretax Income	-$10.50M	-$7.100M	-$12.50M
YoY Change	-11.76%	-43.2%	-70.1%
Income Tax	$1.200M	$900.0K	$1.600M
% Of Pretax Income
Net Earnings	-$9.900M	-$9.000M	-$12.40M
YoY Change	-20.16%	-27.42%	-198.41%
Net Earnings / Revenue	-2.68%	-2.83%	-3.0%
Basic Earnings Per Share	-$0.13	-$0.13	-$0.18
Diluted Earnings Per Share	-$0.13	-$0.13	-$0.18
COMMON SHARES
Basic Shares Outstanding	79.05M shares	78.79M shares	77.30M shares
Diluted Shares Outstanding	77.90M shares	77.70M shares	77.30M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$28.80M	$16.60M	$26.40M
YoY Change	15.66%	-37.12%	-51.29%
Cash & Equivalents	$28.80M	$16.60M	$26.40M
Short-Term Investments
Other Short-Term Assets	$13.60M	$14.70M	$12.20M
YoY Change	22.52%	20.49%	-42.72%
Inventory	$19.90M	$21.30M	$19.50M
Prepaid Expenses
Receivables	$293.6M	$253.7M	$274.4M
Other Receivables	$290.9M	$249.9M	$265.5M
Total Short-Term Assets	$531.2M	$486.5M	$476.6M
YoY Change	10.14%	2.08%	-91.95%
LONG-TERM ASSETS
Property, Plant & Equipment	$222.3M	$228.5M	$237.0M
YoY Change	35.14%	-3.59%	58.74%
Goodwill	$127.0M	$127.0M	$127.5M
YoY Change	-0.08%	-0.39%	14.97%
Intangibles	$182.6M	$186.1M	$204.2M
YoY Change	-7.96%	-8.86%	22.2%
Long-Term Investments	$2.800M	$3.100M	$43.90M
YoY Change	-94.12%	-92.94%	7.33%
Other Assets	$68.10M	$71.10M	$74.80M
YoY Change	-5.94%	-4.95%	80.24%
Total Long-Term Assets	$548.3M	$557.6M	$635.6M
YoY Change	-12.15%	-12.27%	30.89%
TOTAL ASSETS
Total Short-Term Assets	$531.2M	$486.5M	$476.6M
Total Long-Term Assets	$548.3M	$557.6M	$635.6M
Total Assets	$1.080B	$1.044B	$1.112B
YoY Change	-2.43%	-6.12%	-82.64%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$188.7M	$167.0M	$200.4M
YoY Change	3.45%	-16.67%	185.47%
Accrued Expenses	$73.30M	$45.00M	$86.10M
YoY Change	-21.44%	-47.74%	9.54%
Deferred Revenue	$117.3M	$104.9M	$55.10M
YoY Change	25.72%	90.38%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$222.4M	$32.90M	$80.10M
YoY Change	204.66%	-58.93%	-3.26%
Total Short-Term Liabilities	$618.9M	$374.5M	$441.5M
YoY Change	34.05%	-15.18%	-91.93%
LONG-TERM LIABILITIES
Long-Term Debt	$519.6M	$664.3M	$601.0M
YoY Change	-12.54%	10.53%	29.72%
Other Long-Term Liabilities	$55.20M	$107.6M	$63.30M
YoY Change	-7.69%	69.98%	86.18%
Total Long-Term Liabilities	$55.20M	$107.6M	$63.30M
YoY Change	-7.69%	69.98%	86.18%
TOTAL LIABILITIES
Total Short-Term Liabilities	$618.9M	$374.5M	$441.5M
Total Long-Term Liabilities	$55.20M	$107.6M	$63.30M
Total Liabilities	$1.198B	$1.150B	$1.115B
YoY Change	6.4%	3.12%	-81.33%
SHAREHOLDERS EQUITY
Retained Earnings	-$471.0M	-$461.1M	-$428.6M
YoY Change	6.8%	7.58%	143.38%
Common Stock	$327.1M	$326.9M	$330.9M
YoY Change	-1.12%	-1.21%	-7.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)			$5.200M
YoY Change			0.0%
Treasury Stock Shares			1.389M shares
Shareholders Equity	-$150.9M	-$141.1M	-$95.90M
YoY Change
Total Liabilities & Shareholders Equity	$1.080B	$1.044B	$1.112B
YoY Change	-2.43%	-6.12%	-82.64%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	-$9.900M	-$9.000M	-$12.40M
YoY Change	-20.16%	-27.42%	-198.41%
Depreciation, Depletion And Amortization	$6.200M	$10.20M	$10.60M
YoY Change	-1.59%	-3.77%	70.97%
Cash From Operating Activities	$16.20M	-$77.00M	-$63.40M
YoY Change	-21.74%	21.45%	2436.0%
INVESTING ACTIVITIES
Capital Expenditures	$4.500M	$3.700M	$4.600M
YoY Change	-207.14%	-19.57%	43.75%
Acquisitions
YoY Change
Other Investing Activities	$0.00	-$400.0K	$100.0K
YoY Change	-100.0%	-500.0%	-93.75%
Cash From Investing Activities	-$4.500M	$51.20M	-$7.400M
YoY Change	9.76%	-791.89%	-110.9%
FINANCING ACTIVITIES
Cash Dividend Paid		$1.200M	$2.400M
YoY Change		-50.0%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net		$4.600M	$6.200M
YoY Change		-25.81%	-98.26%
Cash From Financing Activities	700.0K	-$38.00M	$51.20M
YoY Change	-104.27%	-174.22%	-242.62%
NET CHANGE
Cash From Operating Activities	16.20M	-$77.00M	-$63.40M
Cash From Investing Activities	-4.500M	$51.20M	-$7.400M
Cash From Financing Activities	700.0K	-$38.00M	$51.20M
Net Change In Cash	12.40M	-$64.20M	-$19.10M
YoY Change	6100.0%	236.13%	-275.23%
FREE CASH FLOW
Cash From Operating Activities	$16.20M	-$77.00M	-$63.40M
Capital Expenditures	$4.500M	$3.700M	$4.600M
Free Cash Flow	$11.70M	-$80.70M	-$68.00M
YoY Change	-53.01%	18.68%	1092.98%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001006837
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2023Q1	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherLiabilitiesCurrent
CY2022Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherLiabilitiesCurrent
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#DebtAndCapitalLeaseObligations
CY2023Q1	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#DebtAndCapitalLeaseObligations
CY2022Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherLiabilitiesCurrent
CY2023Q1	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherLiabilitiesCurrent
CY2023Q1	vate	Preferred Stock Trading Period To Calculate Volume Weighted Average Price PreferredStockTradingPeriodToCalculateVolumeWeightedAveragePrice	P20D
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-35210
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	INNOVATE CORP.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	54-1708481
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	222 Lakeview Ave.
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 1660
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	West Palm Beach
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33401
CY2023Q1	dei	City Area Code CityAreaCode	212
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	235-2691
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	79049423	shares
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	317900000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	412800000	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	274300000	usd
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	363000000.0	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	43600000	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	49800000	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	41700000	usd
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	42600000	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	6300000	usd
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	6900000	usd
CY2023Q1	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	400000	usd
CY2022Q1	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	400000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-4000000.0	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	700000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	15600000	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	12600000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-4000000.0	usd
CY2022Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-500000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	16500000	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-100000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-7100000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-12500000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	900000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1600000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-8000000.0	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-14100000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1000000.0	usd
CY2022Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1700000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-8000000.0	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-9000000.0	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-12400000	usd
CY2023Q1	us-gaap	Dividends Preferred Stock DividendsPreferredStock	1200000	usd
CY2022Q1	us-gaap	Dividends Preferred Stock DividendsPreferredStock	1200000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-10200000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-10200000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-13600000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-13600000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.13
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.13
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.18
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.18
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	77700000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	77700000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	77300000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	77300000	shares
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-14100000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-1000000.0	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	700000	usd
CY2023Q1	vate	Other Comprehensive Income Loss Disposal Of Subsidiary Net Of Tax OtherComprehensiveIncomeLossDisposalOfSubsidiaryNetOfTax	-9100000	usd
CY2022Q1	vate	Other Comprehensive Income Loss Disposal Of Subsidiary Net Of Tax OtherComprehensiveIncomeLossDisposalOfSubsidiaryNetOfTax	0	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-10100000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	700000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-18100000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-13400000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-1700000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-1600000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-16400000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-11800000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	16600000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	80400000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	253700000	usd
CY2022Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	165000000.0	usd
CY2023Q1	us-gaap	Goodwill Goodwill	127000000.0	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	254900000	usd
CY2023Q1	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	180200000	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	165100000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	21300000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	18900000	usd
CY2023Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	0	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	300000	usd
CY2023Q1	us-gaap	Other Assets Current OtherAssetsCurrent	14700000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	16800000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	486500000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	536400000	usd
CY2023Q1	us-gaap	Investments Investments	7700000	usd
CY2022Q4	us-gaap	Investments Investments	59500000	usd
CY2023Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	1700000	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	1700000	usd
CY2023Q1	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	164000000.0	usd
CY2022Q4	us-gaap	Goodwill Goodwill	127100000	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	186100000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	190100000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	71100000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	71900000	usd
CY2023Q1	us-gaap	Assets Assets	1044100000	usd
CY2022Q4	us-gaap	Assets Assets	1151700000	usd
CY2023Q1	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	167000000.0	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	202500000	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	45000000.0	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	65400000	usd
CY2023Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	32900000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	30600000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	104900000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	98600000	usd
CY2023Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	24700000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	20100000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	374500000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	417200000	usd
CY2023Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	3700000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	9100000	usd
CY2023Q1	us-gaap	Debt And Capital Lease Obligations DebtAndCapitalLeaseObligations	664300000	usd
CY2022Q4	us-gaap	Debt And Capital Lease Obligations DebtAndCapitalLeaseObligations	683800000	usd
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	107600000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	71200000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	1150100000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	1181300000	usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	us-gaap	Redeemable Noncontrolling Interest Equity Common Carrying Amount RedeemableNoncontrollingInterestEquityCommonCarryingAmount	-5200000	usd
CY2022Q4	us-gaap	Redeemable Noncontrolling Interest Equity Common Carrying Amount RedeemableNoncontrollingInterestEquityCommonCarryingAmount	43400000	usd
CY2023Q1	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	12100000	usd
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	61000000.0	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	100000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	100000	usd
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	160000000	shares
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	160000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	80537415	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	80216028	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	79049423	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	78787768	shares
CY2023Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	326800000	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	330100000	usd
CY2023Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	1487992	shares
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	1428260	shares
CY2023Q1	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	5400000	usd
CY2022Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	5300000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-461100000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-452100000	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1500000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	5900000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-141100000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-121300000	usd
CY2023Q1	us-gaap	Minority Interest MinorityInterest	23000000.0	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	30700000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-118100000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-90600000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1044100000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1151700000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-90600000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	500000	usd
CY2023Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	100000	usd
CY2023Q1	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	900000	usd
CY2023Q1	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	10700000	usd
CY2023Q1	us-gaap	Minority Interest Period Increase Decrease MinorityInterestPeriodIncreaseDecrease	-100000	usd
CY2023Q1	vate	Increase Decrease Preferred Stock Liability Reclass IncreaseDecreasePreferredStockLiabilityReclass	-41800000	usd
CY2023Q1	vate	Net Income Loss Including Portion Attributableto Noncontrolling Interest Excluding Temporary Equity NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingTemporaryEquity	-6800000	usd
CY2023Q1	vate	Other Comprehensive Income Loss Including Portion Attributableto Noncontrolling Interestand Redeemable Noncontrolling Interest OtherComprehensiveIncomeLossIncludingPortionAttributabletoNoncontrollingInterestandRedeemableNoncontrollingInterest	-9600000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-118100000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-56200000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	800000	usd
CY2022Q1	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	2100000	usd
CY2022Q1	us-gaap	Minority Interest Period Increase Decrease MinorityInterestPeriodIncreaseDecrease	100000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	100000	usd
CY2022Q1	vate	Net Income Loss Including Portion Attributableto Noncontrolling Interest Excluding Temporary Equity NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingTemporaryEquity	-12400000	usd
CY2022Q1	vate	Other Comprehensive Income Loss Including Portion Attributableto Noncontrolling Interestand Redeemable Noncontrolling Interest OtherComprehensiveIncomeLossIncludingPortionAttributabletoNoncontrollingInterestandRedeemableNoncontrollingInterest	600000	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-69300000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-8000000.0	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-14100000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	500000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	800000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	10200000	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	10600000	usd
CY2023Q1	vate	Amortization Of Deferred Financing Costs AmortizationOfDeferredFinancingCosts	1600000	usd
CY2022Q1	vate	Amortization Of Deferred Financing Costs AmortizationOfDeferredFinancingCosts	1200000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-4000000.0	usd
CY2022Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-500000	usd
CY2023Q1	vate	Gain Loss On Equity Method Investments GainLossOnEquityMethodInvestments	16100000	usd
CY2022Q1	vate	Gain Loss On Equity Method Investments GainLossOnEquityMethodInvestments	0	usd
CY2023Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2022Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	100000	usd
CY2023Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-5400000	usd
CY2022Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	400000	usd
CY2023Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	500000	usd
CY2022Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-200000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1600000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	25800000	usd
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	15100000	usd
CY2022Q1	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	22000000.0	usd
CY2023Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	1100000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	1200000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2400000	usd
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2500000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-2500000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-4500000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-36300000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	20200000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-19000000.0	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-7200000	usd
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	6300000	usd
CY2022Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-24000000.0	usd
CY2023Q1	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-1400000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-4900000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	1600000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-200000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-77000000.0	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-63400000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3700000	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4600000	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	300000	usd
CY2022Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	1800000	usd
CY2023Q1	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	0	usd
CY2022Q1	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	4500000	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	54200000	usd
CY2022Q1	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	0	usd
CY2023Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-400000	usd
CY2022Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	100000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	51200000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-7400000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	900000	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	usd
CY2023Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	4600000	usd
CY2022Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	6400000	usd
CY2023Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	40000000.0	usd
CY2022Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	100000000.0	usd
CY2023Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	57000000.0	usd
CY2022Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	40000000.0	usd
CY2023Q1	vate	Payments To Noncontrolling Interest And Redeemable Noncontrolling Interests Sale Of Equity Method Investments PaymentsToNoncontrollingInterestAndRedeemableNoncontrollingInterestsSaleOfEquityMethodInvestments	15900000	usd
CY2022Q1	vate	Payments To Noncontrolling Interest And Redeemable Noncontrolling Interests Sale Of Equity Method Investments PaymentsToNoncontrollingInterestAndRedeemableNoncontrollingInterestsSaleOfEquityMethodInvestments	0	usd
CY2023Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	1200000	usd
CY2022Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	2400000	usd
CY2023Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-200000	usd
CY2022Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	0	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-38000000.0	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	51200000	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-400000	usd
CY2022Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	500000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-64200000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-19100000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	82200000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	47500000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18000000.0	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	28400000	usd
CY2023Q1	us-gaap	Nature Of Operations NatureOfOperations	<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">1. Organization and Business </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">INNOVATE Corp. ("INNOVATE" and, together with its consolidated subsidiaries, the "Company", "we" and "our") is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments. We seek to grow these businesses so that they can generate long-term sustainable free cash flow and attractive returns in order to maximize value for all stakeholders. While the Company generally intends to acquire controlling equity interests in its operating subsidiaries, the Company may invest to a limited extent in a variety of noncontrolling equity interest positions or debt instruments. The Company’s shares of common stock trade on the NYSE under the symbol "VATE".</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company currently has three reportable segments, plus our Other segment, based on management’s organization of the enterprise: Infrastructure, Life Sciences, Spectrum, and Other which includes businesses that do not meet the separately reportable segment thresholds.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:29.25pt">Our Infrastructure segment is comprised of DBM Global Inc. ("DBMG") and its wholly-owned subsidiaries. DBMG is a fully integrated industrial construction, structural steel and facility maintenance provider that provides fabrication and erection of structural steel and heavy steel plate services and also fabricates trusses and girders and specializes in the fabrication and erection of large-diameter water pipe and water storage tanks, as well as 3-D Building Information Modeling (“BIM”) and detailing. DBMG provides these services on commercial, industrial, and infrastructure construction projects such as high- and low-rise buildings and office complexes, hotels and casinos, convention centers, sports arenas and stadiums, shopping malls, hospitals, dams, bridges, mines, metal processing, refineries, pulp and paper mills and power plants. Through GrayWolf Industrial Inc. ("GrayWolf"), DBMG provides integrated solutions for digital engineering, modeling and detailing, construction, heavy equipment installation and facility services including maintenance, repair, and installation to a diverse range of end markets. Through Aitken Manufacturing, Inc., DBMG manufactures pollution control scrubbers, tunnel liners, pressure vessels, strainers, filters, separators and a variety of customized products. Through Banker Steel Holdco, LLC ("Banker Steel"), DBMG provides full-service fabricated structural steel and erection services primarily for the East Coast and Southeast commercial and industrial construction market, in addition to full design-assist services. The Company maintains an approximately 91% controlling interest in DBMG.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:29.25pt">Our Life Sciences segment is comprised of Pansend Life Sciences, LLC ("Pansend"), its subsidiaries and equity method investments. Pansend maintains controlling interests of approximately 80% in Genovel Orthopedics, Inc. ("Genovel"), which seeks to develop products to treat early osteoarthritis of the knee and approximately 57% in R2 Technologies, Inc. ("R2"), which develops aesthetic and medical technologies for the skin. Pansend also invests in other early stage or developmental stage healthcare companies including an approximately 46% interest in MediBeacon Inc. ("MediBeacon"), a medical technology company specializing in the advances of fluorescent tracer agents and transdermal measurement, potentially enabling real-time, direct monitoring of kidney function, and an approximately 26% interest in Triple Ring Technologies, Inc. ("Triple Ring"), a science and technology co-development company. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:29.25pt">Our Spectrum segment is comprised of HC2 Broadcasting Holdings Inc. ("Broadcasting") and its subsidiaries. Broadcasting strategically acquired and operates over-the-air broadcasting stations across the United States. The Company maintains a 98% controlling interest in Broadcasting and maintains a controlling interest of approximately 77%, inclusive of approximately 10% proxy and voting rights from minority holders of DTV America Corporation ("DTV"). On a fully diluted basis, the Company would have an approximately 86% controlling interest in Broadcasting.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:29.25pt">Our Other segment represents all other businesses or investments that do not meet the definition of a segment individually or in the aggregate. Included in the Other segment is the former Marine Services segment, which includes its holding company, Global Marine Holdings, LLC ("GMH"), in which the Company maintains approximately 73% controlling interest. GMH's results include its subsidiary's 19% equity method investment in HMN International Co., Ltd., formerly known as Huawei Marine Networks Co. (“HMN”), until it was sold on March 6, 2023. Refer to Note 6. Investments for additional information.</span></div>
CY2023Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	segment
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	412800000	usd
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates and Assumptions</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The preparation of the Company’s Consolidated Financial Statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates and assumptions used.</span></div>
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	317900000	usd
CY2023Q1	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	249400000	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	250400000	usd
CY2023Q1	vate	Costs Incurred On Contracts In Progress CostsIncurredOnContractsInProgress	2472500000	usd
CY2022Q4	vate	Costs Incurred On Contracts In Progress CostsIncurredOnContractsInProgress	2503300000	usd
CY2023Q1	vate	Estimated Earnings On Contracts EstimatedEarningsOnContracts	405900000	usd
CY2022Q4	vate	Estimated Earnings On Contracts EstimatedEarningsOnContracts	378900000	usd
CY2023Q1	vate	Cost Earned On Uncompleted Contracts Gross CostEarnedOnUncompletedContractsGross	2878400000	usd
CY2022Q4	vate	Cost Earned On Uncompleted Contracts Gross CostEarnedOnUncompletedContractsGross	2882200000	usd
CY2023Q1	vate	Progress Billing On Contract ProgressBillingOnContract	2803100000	usd
CY2022Q4	vate	Progress Billing On Contract ProgressBillingOnContract	2815700000	usd
CY2023Q1	vate	Cost Earned On Uncompleted Contracts Net CostEarnedOnUncompletedContractsNet	75300000	usd
CY2022Q4	vate	Cost Earned On Uncompleted Contracts Net CostEarnedOnUncompletedContractsNet	66500000	usd
CY2023Q1	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	180200000	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	165100000	usd
CY2023Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	104900000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	98600000	usd
CY2023Q1	vate	Contract With Customer Net Asset Liability ContractWithCustomerNetAssetLiability	75300000	usd
CY2022Q4	vate	Contract With Customer Net Asset Liability ContractWithCustomerNetAssetLiability	66500000	usd
CY2023Q1	us-gaap	Construction In Progress Gross ConstructionInProgressGross	245600000	usd
CY2022Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	244800000	usd
CY2023Q1	us-gaap	Unbilled Contracts Receivable UnbilledContractsReceivable	200000	usd
CY2022Q4	us-gaap	Unbilled Contracts Receivable UnbilledContractsReceivable	200000	usd
CY2023Q1	us-gaap	Accounts Receivable Gross AccountsReceivableGross	4000000.0	usd
CY2022Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	5900000	usd
CY2023Q1	us-gaap	Other Receivables OtherReceivables	4300000	usd
CY2022Q4	us-gaap	Other Receivables OtherReceivables	4500000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	400000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	500000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	253700000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	254900000	usd
CY2023Q1	us-gaap	Accounts Receivable Change In Method Credit Loss Expense Reversal AccountsReceivableChangeInMethodCreditLossExpenseReversal	0	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-100000	usd
CY2022Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	200000	usd
CY2023Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	18500000	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	15700000	usd
CY2023Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	800000	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	1200000	usd
CY2023Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	2000000.0	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	2000000.0	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	21300000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	18900000	usd
CY2023Q1	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	0	usd
CY2023Q1	us-gaap	Equity Method Investments EquityMethodInvestments	3100000	usd
CY2023Q1	us-gaap	Equity Method Investments Fair Value Disclosure EquityMethodInvestmentsFairValueDisclosure	4600000	usd
CY2023Q1	us-gaap	Investments Investments	7700000	usd
CY2022Q4	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	11300000	usd
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	43600000	usd
CY2022Q4	us-gaap	Equity Method Investments Fair Value Disclosure EquityMethodInvestmentsFairValueDisclosure	4600000	usd
CY2022Q4	us-gaap	Investments Investments	59500000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-4000000	usd
CY2022Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-500000	usd
CY2023Q1	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	288300000	usd
CY2022Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	283500000	usd
CY2023Q1	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	124300000	usd
CY2022Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	118500000	usd
CY2023Q1	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	164000000.0	usd
CY2022Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	165000000.0	usd
CY2023Q1	us-gaap	Depreciation Depreciation	6300000	usd
CY2022Q1	us-gaap	Depreciation Depreciation	6400000	usd
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	2700000	usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	2100000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	127100000	usd
CY2023Q1	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-100000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	127000000.0	usd
CY2023Q1	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	106300000	usd
CY2022Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	106300000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	129600000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	49800000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	79800000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	129700000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	45900000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	83800000	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3900000	usd
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	4100000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	64500000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	65800000	usd
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	2700000	usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	2100000	usd
CY2023Q1	vate	Lease Right Of Use Asset LeaseRightOfUseAsset	67200000	usd
CY2022Q4	vate	Lease Right Of Use Asset LeaseRightOfUseAsset	67900000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	15600000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	17100000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	53600000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	53800000	usd
CY2023Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	2700000	usd
CY2022Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	2100000	usd
CY2023Q1	vate	Lease Liability LeaseLiability	71900000	usd
CY2022Q4	vate	Lease Liability LeaseLiability	73000000.0	usd
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	100000	usd
CY2022Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	0	usd
CY2023Q1	vate	Finance Lease Cost FinanceLeaseCost	100000	usd
CY2022Q1	vate	Finance Lease Cost FinanceLeaseCost	0	usd
CY2023Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	5900000	usd
CY2022Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	5900000	usd
CY2023Q1	us-gaap	Variable Lease Cost VariableLeaseCost	100000	usd
CY2022Q1	us-gaap	Variable Lease Cost VariableLeaseCost	100000	usd
CY2023Q1	us-gaap	Sublease Income SubleaseIncome	200000	usd
CY2022Q1	us-gaap	Sublease Income SubleaseIncome	200000	usd
CY2023Q1	us-gaap	Lease Cost LeaseCost	5900000	usd
CY2022Q1	us-gaap	Lease Cost LeaseCost	5800000	usd
CY2023Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	100000	usd
CY2022Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	0	usd
CY2023Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	6300000	usd
CY2022Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	6200000	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	600000	usd
CY2022Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	0	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	3900000	usd
CY2022Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	6500000	usd
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y4M24D
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y6M
CY2023Q1	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P2Y
CY2022Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P1Y4M24D
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.055
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.053
CY2023Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.056
CY2022Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.057
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	14500000	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	1800000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	15300000	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	400000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	11800000	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	300000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	8300000	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	200000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	6000000.0	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	200000	usd
CY2023Q1	vate	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	28800000	usd
CY2023Q1	vate	Finance Lease Liability To Be Paid After Year Four FinanceLeaseLiabilityToBePaidAfterYearFour	0	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	84700000	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	2900000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	15500000	usd
CY2023Q1	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	200000	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	69200000	usd
CY2023Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	2700000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	64500000	usd
CY2023Q1	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	400000	usd
CY2022Q4	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	400000	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	45000000.0	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	65800000	usd
CY2023Q1	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	1400000	usd
CY2022Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	1500000	usd
CY2023Q1	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	5200000	usd
CY2022Q4	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	4600000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	71100000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	71900000	usd
CY2023Q1	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	16200000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	18900000	usd
CY2023Q1	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	21700000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	30800000	usd
CY2023Q1	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	6700000	usd
CY2022Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	15300000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	65400000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	15600000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	17100000	usd
CY2023Q1	vate	Redeemable Preferred Stock Current RedeemablePreferredStockCurrent	7000000.0	usd
CY2022Q4	vate	Redeemable Preferred Stock Current RedeemablePreferredStockCurrent	0	usd
CY2023Q1	vate	Other Liabilities Current Other OtherLiabilitiesCurrentOther	2100000	usd
CY2022Q4	vate	Other Liabilities Current Other OtherLiabilitiesCurrentOther	3000000.0	usd
CY2023Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	24700000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	20100000	usd
CY2023Q1	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	664300000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	53600000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	53800000	usd
CY2023Q1	vate	Redeemable Preferred Stock Liability Noncurrent RedeemablePreferredStockLiabilityNoncurrent	34800000	usd
CY2022Q4	vate	Redeemable Preferred Stock Liability Noncurrent RedeemablePreferredStockLiabilityNoncurrent	0	usd
CY2023Q1	vate	Other Liabilities Noncurrent Other OtherLiabilitiesNoncurrentOther	19200000	usd
CY2022Q4	vate	Other Liabilities Noncurrent Other OtherLiabilitiesNoncurrentOther	17400000	usd
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	107600000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	71200000	usd
CY2023Q1	us-gaap	Long Term Debt And Capital Lease Obligations Including Current Maturities LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities	706500000	usd
CY2022Q4	us-gaap	Long Term Debt And Capital Lease Obligations Including Current Maturities LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities	725300000	usd
CY2023Q1	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	9300000	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	10900000	usd
CY2023Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	32900000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	30600000	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	200000	usd
CY2022Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	683800000	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	1800000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	60900000	usd
CY2023Q1	vate	Long Term Debt And Lease Obligations Maturities Repayments Of Principal Remainder Of Year LongTermDebtAndLeaseObligationsMaturitiesRepaymentsOfPrincipalRemainderOfYear	62700000	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	400000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	253100000	usd
CY2023Q1	vate	Long Term Debt And Lease Obligations Maturities Repayments Of Principal In Year One LongTermDebtAndLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearOne	253500000	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	300000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	46800000	usd
CY2023Q1	vate	Long Term Debt And Lease Obligations Maturities Repayments Of Principal In Year Two LongTermDebtAndLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo	47100000	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	200000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	469700000	usd
CY2023Q1	vate	Long Term Debt And Lease Obligations Maturities Repayments Of Principal In Year Three LongTermDebtAndLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree	469900000	usd
CY2023Q1	vate	Volume Weighted Average Price Threshold Percentage VolumeWeightedAveragePriceThresholdPercentage	1.50
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	3.25
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	1500	shares
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	0	usd
CY2023Q1	vate	Long Term Debt And Lease Obligations Maturities Repayments Of Principal In Year Four LongTermDebtAndLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour	200000	usd
CY2023Q1	vate	Finance Lease Liability To Be Paid After Year Four FinanceLeaseLiabilityToBePaidAfterYearFour	0	usd
CY2023Q1	vate	Long Term Debt Maturity After Year Four LongTermDebtMaturityAfterYearFour	0	usd
CY2023Q1	vate	Long Term Debt And Lease Obligations Maturities Repayments Of Principal After Year Four LongTermDebtAndLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFour	0	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	2900000	usd
CY2023Q1	vate	Debt Including Interest Payable DebtIncludingInterestPayable	830500000	usd
CY2023Q1	vate	Long Term Debt And Lease Obligation Including Current Maturities And Interest LongTermDebtAndLeaseObligationIncludingCurrentMaturitiesAndInterest	833400000	usd
CY2023Q1	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	200000	usd
CY2023Q1	vate	Long Term Debt Maturities Interest Included In Payments LongTermDebtMaturitiesInterestIncludedInPayments	126700000	usd
CY2023Q1	vate	Long Term Debt And Lease Obligations Maturities Interest Included In Payments LongTermDebtAndLeaseObligationsMaturitiesInterestIncludedInPayments	126900000	usd
CY2023Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	2700000	usd
CY2023Q1	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	703800000	usd
CY2023Q1	us-gaap	Long Term Debt And Capital Lease Obligations Including Current Maturities LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities	706500000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	900000	usd
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	4.06
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1600000	usd
CY2023Q1	vate	Income Tax Expense Benefit Interim Tax IncomeTaxExpenseBenefitInterimTax	-1100000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	162900000	usd
CY2023Q1	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	58700000	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	500000	usd
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	800000	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4715859	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	5.13
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	280791	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4995150	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	5.02
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4995150	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	5.02
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	100000	usd
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P1Y6M
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod	P10Y
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	0	shares
CY2023Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	0	usd
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2021Q3	vate	Proceed From Exchange For Accrued And Unpaid Dividend ProceedFromExchangeForAccruedAndUnpaidDividend	300000	usd
CY2023Q1	us-gaap	Preferred Stock Dividend Rate Percentage PreferredStockDividendRatePercentage	0.0750
CY2023Q1	vate	Preferred Stock Accreting Dividends Accruing Rate PreferredStockAccretingDividendsAccruingRate	0.0400
CY2023Q1	vate	Preferred Stock Accreting Dividends Accruing Rate Required Threshold PreferredStockAccretingDividendsAccruingRateRequiredThreshold	0.0725
CY2023Q1	vate	Preferred Stock Force Conversion Trading Period To Calculate Volume Weighted Average Price PreferredStockForceConversionTradingPeriodToCalculateVolumeWeightedAveragePrice	P30D
CY2023Q1	vate	Volume Weighted Average Price Threshold Percentage VolumeWeightedAveragePriceThresholdPercentage	1.50
CY2023Q1	vate	Volume Weighted Average Price Threshold Percentage VolumeWeightedAveragePriceThresholdPercentage	1.50
CY2023Q1	vate	Preferred Stock Force Conversion Trading Period To Calculate Volume Weighted Average Price PreferredStockForceConversionTradingPeriodToCalculateVolumeWeightedAveragePrice	P30D
CY2023Q1	vate	Preferred Stock Consent Rights Percentage PreferredStockConsentRightsPercentage	0.75
CY2023Q1	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	300000	usd
CY2022Q1	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	300000	usd
CY2021Q3	vate	Tax Benefits Preservation Plan Outstanding Shares Ownership Threshold TaxBenefitsPreservationPlanOutstandingSharesOwnershipThreshold	0.049
CY2018Q3	vate	Lessee Lease Term LesseeLeaseTerm	P75M
CY2023Q1	vate	Number Of Geographic Reportable Segments NumberOfGeographicReportableSegments	1	segment
CY2023Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	segment
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	317900000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	412800000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-4000000.0	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	700000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-4000000.0	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	700000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	15600000	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	12600000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-4000000.0	usd
CY2022Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-500000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	16500000	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-100000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-7100000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-12500000	usd
CY2023Q1	vate	Depreciation Depletion And Amortization Nonproduction Including Cost Of Revenue DepreciationDepletionAndAmortizationNonproductionIncludingCostOfRevenue	10200000	usd
CY2022Q1	vate	Depreciation Depletion And Amortization Nonproduction Including Cost Of Revenue DepreciationDepletionAndAmortizationNonproductionIncludingCostOfRevenue	10600000	usd
CY2023Q1	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	3700000	usd
CY2022Q1	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	4600000	usd
CY2023Q1	us-gaap	Investments Investments	7700000	usd
CY2022Q4	us-gaap	Investments Investments	59500000	usd
CY2023Q1	us-gaap	Equity Method Investments EquityMethodInvestments	3100000	usd
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	43600000	usd
CY2023Q1	us-gaap	Assets Assets	1044100000	usd
CY2022Q4	us-gaap	Assets Assets	1151700000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-8000000.0	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-14100000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1000000.0	usd
CY2022Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1700000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-9000000.0	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-12400000	usd
CY2023Q1	us-gaap	Dividends Preferred Stock DividendsPreferredStock	1200000	usd
CY2022Q1	us-gaap	Dividends Preferred Stock DividendsPreferredStock	1200000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-10200000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-10200000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-13600000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-13600000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	77700000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	77700000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	77300000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	77300000	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.13
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.13
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.18
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.18
CY2022Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	1500000	usd
CY2022Q1	us-gaap	Gain Loss On Sale Of Equity Investments GainLossOnSaleOfEquityInvestments	0	usd
CY2023Q1	vate	Gain Loss On Step Up Of Equity Method Investment GainLossOnStepUpOfEquityMethodInvestment	3800000	usd
CY2022Q1	vate	Gain Loss On Step Up Of Equity Method Investment GainLossOnStepUpOfEquityMethodInvestment	0	usd
CY2023Q1	vate	Other Income Expense Net OtherIncomeExpenseNet	400000	usd
CY2022Q1	vate	Other Income Expense Net OtherIncomeExpenseNet	-100000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	16500000	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-100000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	80400000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	45500000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	300000	usd
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	2000000.0	usd
CY2021Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	0	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	82200000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	47500000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	16600000	usd
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	26400000	usd
CY2023Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	0	usd
CY2022Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	2000000.0	usd
CY2023Q1	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	1400000	usd
CY2022Q1	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	0	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18000000.0	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	28400000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	19500000	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	18600000	usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	5000000.0	usd
CY2022Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	400000	usd
CY2023Q1	us-gaap	Noncash Or Part Noncash Acquisition Payables Assumed1 NoncashOrPartNoncashAcquisitionPayablesAssumed1	1400000	usd
CY2022Q1	us-gaap	Noncash Or Part Noncash Acquisition Payables Assumed1 NoncashOrPartNoncashAcquisitionPayablesAssumed1	0	usd

Files In Submission

Name	View Source	Status
0001006837-23-000063-index-headers.html	Edgar Link	pending
0001006837-23-000063-index.html	Edgar Link	pending
0001006837-23-000063.txt	Edgar Link	pending
0001006837-23-000063-xbrl.zip	Edgar Link	pending
exhibit101-q110q2023.htm	Edgar Link	pending
exhibit102-q110q2023.htm	Edgar Link	pending
exhibit103-q110q2023.htm	Edgar Link	pending
exhibit104-q110q2023.htm	Edgar Link	pending
exhibit105-q110q2023.htm	Edgar Link	pending
exhibit106-q110q2023.htm	Edgar Link	pending
exhibit311-q110q2023.htm	Edgar Link	pending
exhibit312-q110q2023.htm	Edgar Link	pending
exhibit321-q110q2023.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
vate-20230331.htm	Edgar Link	pending
vate-20230331.xsd	Edgar Link	pending
vate-20230331_g1.jpg	Edgar Link	pending
vate-20230331_cal.xml	Edgar Link	unprocessable
vate-20230331_def.xml	Edgar Link	unprocessable
vate-20230331_pre.xml	Edgar Link	unprocessable
vate-20230331_lab.xml	Edgar Link	unprocessable
vate-20230331_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$VATE
INNOVATE Corp. Stock $vate

2023 Q2 Form 10-Q Financial Statement

#000100683723000063 Filed on May 10, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VATE INNOVATE Corp. Stock $vate

2023 Q2 Form 10-Q Financial Statement

#000100683723000063 Filed on May 10, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VATE
INNOVATE Corp. Stock $vate